CRSP
CRISPR Therapeutics AG
$52.96
+2.40% (+$1.24)
Volume
1.52M
52W High
$78.48
52W Low
$44.12
Market Cap
$4.60B
Next Earnings Report
Last Reported
Aug 3, 2026 Beat
Actual: -$0.94
vs. Consensus: -$1.10
Price Chart
EPS History: Consensus vs Actual
Last 10 quartersPrice Movement Around Earnings
Q2 2026
Aug 3, 2026
1-Day:
+7.06%
Q1 2026
May 11, 2026
1-Day:
-2.18%
Q1 2026
May 5, 2026
1-Day:
+5.15%
Q1 2026
May 4, 2026
1-Day:
-2.24%
Revenue & Financial Performance
| Quarter | Revenue | YoY Growth | Gross Margin | Op Margin | Net Income |
|---|---|---|---|---|---|
| Q4'25 | $864,000 | -97.5% | -6,770.8% | -10,000.0% | -$130.6M |
| Q3'25 | $889,000 | +47.7% | -7,177.1% | -10,000.0% | -$106.4M |
| Q2'25 | $892,000 | +72.5% | -5,062.0% | -10,000.0% | -$208.5M |
| Q1'25 | $865,000 | +71.6% | -6,548.4% | -10,000.0% | -$136.0M |
| Q4'24 | $35.0M | -82.5% | 100.0% | -184.5% | -$37.3M |
| Q3'24 | $602,000 | -99.1% | -1,852.7% | -10,000.0% | -$85.9M |
| Q2'24 | $517,000 | -99.5% | -10,000.0% | -10,000.0% | -$126.4M |
| Q1'24 | $504,000 | +8,300.0% | -10,000.0% | -10,000.0% | -$116.6M |
Company Information
Symbol
CRSP
Company
CRISPR Therapeutics AG
Market Cap
$4.60B